Assurant, Inc. 5.25% Subordinat
Assurant, Inc. 5.25% Subordinat (AIZN) Financial Performance & Income Statement Overview
Analyze Assurant, Inc. 5.25% Subordinat (AIZN) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Assurant, Inc. 5.25% Subordinat (AIZN) Income Statement & Financial Overview
View the income breakdown for Assurant, Inc. 5.25% Subordinat AIZN across both annual and quarterly reports.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $3.07B | $3.10B | $2.97B | $2.92B |
Cost of Revenue | $779.70M | $670.50M | $776.80M | $696.10M |
Gross Profit | $2.29B | $2.43B | $2.19B | $2.23B |
Gross Profit Ratio | $0.75 | $0.78 | $0.74 | $0.76 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Expenses | $2.11B | $2.18B | $2.04B | $2.00B |
Total Costs & Expenses | $2.89B | $2.85B | $2.82B | $2.69B |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $26.80M | $26.80M | $26.70M | $26.70M |
Depreciation & Amortization | $56.70M | $63.90M | $58.50M | $50.50M |
EBITDA | $267.20M | $340.70M | $236.70M | $310.10M |
EBITDA Ratio | $0.09 | $0.11 | $0.08 | $0.11 |
Operating Income | $183.70M | $250.00M | $151.50M | $232.90M |
Operating Income Ratio | $0.06 | $0.08 | $0.05 | $0.08 |
Other Income/Expenses (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
Income Before Tax | $183.70M | $250.00M | $151.50M | $232.90M |
Income Before Tax Ratio | $0.06 | $0.08 | $0.05 | $0.08 |
Income Tax Expense | $37.10M | $48.70M | $17.70M | $44.20M |
Net Income | $146.60M | $201.30M | $133.80M | $188.70M |
Net Income Ratio | $0.05 | $0.06 | $0.05 | $0.06 |
EPS | $2.86 | $3.89 | $2.56 | $3.59 |
Diluted EPS | $2.83 | $3.87 | $2.55 | $3.58 |
Weighted Avg Shares Outstanding | $51.28M | $51.70M | $52.20M | $52.50M |
Weighted Avg Shares Outstanding (Diluted) | $51.73M | $52.08M | $52.46M | $52.72M |
Over the past four quarters, Assurant, Inc. 5.25% Subordinat demonstrated steady revenue growth, increasing from $2.92B in Q2 2024 to $3.07B in Q1 2025. Operating income reached $183.70M in Q1 2025, maintaining a consistent 6% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $267.20M, reflecting operational efficiency. Net income dropped to $146.60M, with EPS at $2.86. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan